Prosecution Insights
Prosecution Insights
5 pending office actions • 1 client • 5 examiners • 3 art units • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| §102 only | 1 (20%) |
| §112 only | 1 (20%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WANG, RUIXUE | 1 | 57.6% | +23.2% |
| KELLY, ROBERT M | 1 | 74.1% | +24.6% |
| THUESON, HANNA MARIE | 1 | 71.4% | +30.8% |
| LEITH, NANCY J | 1 | 74.7% | +43.8% |
| DACE DENITO, ALEXANDRA GERALDINE | 1 | 56.5% | +36.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009476 | BACULOVIRUS EXPRESSION SYSTEMS | THUESON, HANNA MARIE | 114d overdue |
| 18009557 | TANDEM ANELLOVIRUS CONSTRUCTS | LEITH, NANCY J | 81d overdue |
| 18250621 | CHICKEN ANEMIA VIRUS (CAV)-BASED VECTORS | WANG, RUIXUE | 73d overdue |
| 17413297 | ANELLOSOMES FOR DELIVERING PROTEIN REPLACEMENT THERAPEUTIC MODALITIES | DACE DENITO, ALEXANDRA GERALDINE | 45d overdue |
| 18010674 | METHODS OF IDENTIFYING AND CHARACTERIZING ANELLOVIRUSES AND USES THEREOF | KELLY, ROBERT M | 69d |
| Client (Assignee) | Pending OAs |
|---|---|
| Flagship Pioneering | 5 |
| Art Unit | Apps |
|---|---|
| 1638 | 2 |
| 1636 | 2 |
| 1672 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18250621 | CHICKEN ANEMIA VIRUS (CAV)-BASED VECTORS | Flagship Pioneering Innovations V, Inc. | WANG, RUIXUE | 1672 | §103 | Non-Final OA | 73d overdue | Pending | Apr 26, 2023 |
| 18010674 | METHODS OF IDENTIFYING AND CHARACTERIZING ANELLOVIRUSES AND USES THEREOF | Flagship Pioneering Innovations V, Inc. | KELLY, ROBERT M | 1638 | §112 | Non-Final OA | 69d | Pending | Dec 15, 2022 |
| 18009476 | BACULOVIRUS EXPRESSION SYSTEMS | Flagship Pioneering Innovations V, Inc. | THUESON, HANNA MARIE | 1638 | §102 | Non-Final OA | 114d overdue | Pending | Dec 09, 2022 |
| 18009557 | TANDEM ANELLOVIRUS CONSTRUCTS | Flagship Pioneering Innovations V, Inc. | LEITH, NANCY J | 1636 | §103 | Final Rejection | 81d overdue | Pending | Dec 09, 2022 |
| 17413297 | ANELLOSOMES FOR DELIVERING PROTEIN REPLACEMENT THERAPEUTIC MODALITIES | Flagship Pioneering Innovations V, Inc. | DACE DENITO, ALEXANDRA GERALDINE | 1636 | Other | Non-Final OA | 45d overdue | Pending | Jun 11, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial